ADVERSE DRUG EVENT
Clinical trials for ADVERSE DRUG EVENT explained in plain language.
Never miss a new study
Get alerted when new ADVERSE DRUG EVENT trials appear
Sign up with your email to follow new studies for ADVERSE DRUG EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell attack: new hope for advanced melanoma patients
Disease control CompletedThis study tested a new treatment called GC101 TIL for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells, grown in a lab, to fight the cancer. The goal was to check safety and see if tumors shrink. 18 patient…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Immune cells from tumors show promise in advanced cancer trial
Disease control CompletedThis early-stage trial tested a therapy made from a patient's own immune cells (tumor-infiltrating lymphocytes) to fight advanced solid tumors like melanoma, cervical cancer, and lung cancer. 43 adults participated to find the safest dose and check for side effects. The goal was …
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New tool aims to predict Drug-Related ER returns
Knowledge-focused CompletedThis study tested a risk prediction tool (ADE-RED) to identify emergency department patients at high risk for adverse drug events that could lead to a return visit or hospitalization. Researchers enrolled 471 patients and tracked whether the tool helped reduce these events. The g…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Massive study checks safety of nighttime urination drug
Knowledge-focused CompletedThis study looked at medical records from over 1 million people in Denmark, Sweden, and Germany to check the safety of the drug NOCDURNA. NOCDURNA is used to treat frequent nighttime urination caused by a condition where the body makes too much urine at night. The researchers foc…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: Ferring Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 23, 2026 12:44 UTC